NRX-2663
NRX-2663 is an enhancer of the interaction between β-catenin, and its cognate E3 ligase, SCFβ-TrCP. NRX-2663 enhances the binding of β-catenin peptide for β-TrCP with an EC50 of 22.9 μM and a Kd of 54.8 nM[1].
Product Specifications
CAS Number
2763260-34-8
UNSPSC
12352005
Target
E1/E2/E3 Enzyme; β-catenin
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; Stem Cell/Wnt
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/nrx-2663.html
Concentration
10mM
Purity
98.96
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
OC(C1=CC=CC(NC(C2=C(C=C(NC2=O)C(F)(F)F)OC3=CC=CC=C3)=O)=C1)=O
Molecular Formula
C20H13F3N2O5
Molecular Weight
418.32
References & Citations
[1]Kyle R Simonetta, et al. Prospective discovery of small molecule enhancers of an E3 ligase-substrate interaction. Nat Commun. 2019 Mar 29;10 (1) :1402.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A08730-1-carrier-free 100 µg/Vial
Anti-SP6 Antibody Picoband® (Carrier-free Conjugate)
Sign In for Pricing
View Details 
MBS6002480-01 0.02 mg
STAT3, phosphorylated (Tyr705) (Signal Transducer and Activator of Transcription 3, Acute-phase Response Factor, APRF, FLJ20882, MGC16063)
Sign In for Pricing
View Details